SCHEMBL30689293

SCHEMBL30689293

C=C(Cc1nc(-c2ccc(Oc3ncccc3C(F)(F)F)cc2S(C)(=O)=O)no1)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ DRD1 P21728 3/20 0.38
▸ SCN9A Q15858 4/20 0.38
▸ FPR2 P25090 1/20 0.38
▸ SCN5A Q14524 1/20 0.36
▸ KCNH2 Q12809 2/20 0.35
▸ GSTP1 P09211 3/20 0.34
▸ MGLL Q99685 1/20 0.34
▸ P2RX3 P56373 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689390 0.89 PPARG (0.37) DRD1GSTP1
SCHEMBL30689425 0.78 MAPT (0.42) DRD1KCNH2
SCHEMBL30689401 0.77 DRD1 (0.44) DRD1SCN9ASCN5AKCNH2GSTP1
SCHEMBL30689426 0.76 CNR2 (0.41) KCNH2GSTP1
SCHEMBL30689373 0.74 PPARG (0.39) DRD1KCNH2
SCHEMBL30689352 0.71 PPARG (0.38) KCNH2GSTP1P2RX3
SCHEMBL31527931 0.71 MAPT (0.42) SCN5AKCNH2GSTP1
SCHEMBL31527877 0.71 GSTP1 (0.44) DRD1SCN5AKCNH2GSTP1
SCHEMBL31527956 0.69 GSTP1 (0.43) SCN5AKCNH2GSTP1
SCHEMBL30689305 0.69 IP6K1 (0.38) SCN5AKCNH2GSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP claimed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO claimed
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback